VBSN IVF Hartmann Holding AG

SWX · CH · Healthcare · Medical Instruments & Supplies · ivf.hartmann.info

125.00CHF-3.47%Mkt Cap: 339.73M $P/E: 14.743d ago

IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company offers medical devices; hygiene products, body care, hair care, and breast feeding aids; and disinfectants. It also …

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Societe anonyme

$71.20BUSDP/E 26.7

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech

$22.02BUSDP/E 69.2

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.20BUSDP/E 71.6

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap339.73M USD

Enterprise Value217.12M USD

Revenue (TTM)184.72M USD

Gross Profit102.51M USD

Net Income (TTM)20.88M USD

Revenue/Share67.42 CHF

Last Price125.00 CHF

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees279

CountryCH

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)14.74

P/E (Forward)—

PEG3.47

EV/EBITDA7.64

EV/Revenue1.18

P/S1.84

P/B1.92

EPS (TTM)8.47

EPS (Forward)—

52W Range

120.5015% of range150.00

52W High150.00 CHF

52W Low120.50 CHF

Profitability

Gross Margin55.56%

Oper. Margin13.57%

EBITDA Margin15.38%

Profit Margin11.32%

ROE11.77%

ROA9.33%

Growth

Revenue Growth2.60%

Earnings Growth-6.70%

Cash Flow & Leverage

Operating CF24.49M USD

CapEx (TTM)4.54M USD

FCF Margin7.52%

FCF Yield4.09%

Net Debt-126.69M USD

Net Debt/EBITDA-4.46

Balance Sheet

Debt/Equity0.01

Current Ratio4.34

Quick Ratio3.73

Book Value/Sh65.26 CHF

Cash/Share46.93 CHF

Dividends

Fwd Div Rate3.80 CHF

Trail. Div Rate0.00 CHF

Div. Yield2.93%

5Y Avg Yield2.15%

Payout Ratio44.86%

Ex-Div DateApr 16, 2026

Pay DateApr 23, 2025

Splits

Last Split10:1

Split DateJul 16, 2012

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.2.38M

Float2.38M

Insiders76.75%

Institutions1.53%

Technical

SMA 50128.57 (-2.8%)

SMA 200134.12 (-6.8%)

Beta0.23

S&P 52W Chg14.58%

Avg Vol (30d)195

Avg Vol (10d)100

Technical Indicators

RSI (14)45.8

MACD-0.5664

MACD Signal-0.8108

MACD Hist.+0.2444

BB Upper132.59 CHF

BB Middle126.83 CHF

BB Lower121.06 CHF

BB Width9.10%

ATR (14)3.270 CHF

Vol Ratio (20d)0.47x